Share this article
Share this article
WASHINGTON, May 19, 2021 /PRNewswire/ IndyGeneUS AI (pronounced indigenous) has acquired genomic research and testing capabilities through partnerships. This pathogen sequencing capacity has emerged at a pivotal moment in the efforts across the continent to enhance genomic surveillance and track COVID-19 variant strains.
IndyGeneUS AI secures pathogen sequencing capability to support COVID-19 genomic surveillance initiatives. We must move quickly to address the threat that COVID-19 and its variants pose to the entire continent of Africa.
Yusuf Henriques, founder and CEO of IndyGeneUS, shared how critical this work is. We must move quickly to address the threat that COVID-19 and its variants pose to the entire continent of Africa. Our partners understand this urgency and are all aligned to support this mission.